BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 17213229)

  • 21. The role of biomarkers and genetics in peripheral arterial disease.
    McDermott MM; Lloyd-Jones DM
    J Am Coll Cardiol; 2009 Sep; 54(14):1228-37. PubMed ID: 19778662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-grade inflammation can partly explain the association between the metabolic syndrome and either coronary artery disease or severity of peripheral arterial disease: the CODAM study.
    Jacobs M; van Greevenbroek MM; van der Kallen CJ; Ferreira I; Blaak EE; Feskens EJ; Jansen EH; Schalkwijk CG; Stehouwer CD
    Eur J Clin Invest; 2009 Jun; 39(6):437-44. PubMed ID: 19397692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxidized phospholipids, lipoprotein(a), lipoprotein-associated phospholipase A2 activity, and 10-year cardiovascular outcomes: prospective results from the Bruneck study.
    Kiechl S; Willeit J; Mayr M; Viehweider B; Oberhollenzer M; Kronenberg F; Wiedermann CJ; Oberthaler S; Xu Q; Witztum JL; Tsimikas S
    Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1788-95. PubMed ID: 17541022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease.
    Wannamethee SG; Lowe GD; Shaper AG; Rumley A; Lennon L; Whincup PH
    Eur Heart J; 2005 Sep; 26(17):1765-73. PubMed ID: 15817606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel and traditional cardiovascular risk factors for peripheral arterial disease in incident-dialysis patients.
    Jaar BG; Plantinga LC; Astor BC; Fink NE; Longenecker C; Tracy RP; Marcovina SM; Powe NR; Coresh J
    Adv Chronic Kidney Dis; 2007 Jul; 14(3):304-13. PubMed ID: 17603986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Different calculations of ankle-brachial index and their impact on cardiovascular risk prediction.
    Espinola-Klein C; Rupprecht HJ; Bickel C; Lackner K; Savvidis S; Messow CM; Munzel T; Blankenberg S;
    Circulation; 2008 Aug; 118(9):961-7. PubMed ID: 18697822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The predictive value of brachial-ankle pulse wave velocity in coronary atherosclerosis and peripheral artery diseases in urban Chinese patients.
    Xu Y; Wu Y; Li J; Ma W; Guo X; Luo Y; Hu D
    Hypertens Res; 2008 Jun; 31(6):1079-85. PubMed ID: 18716354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beta2-microglobulin as a biomarker in peripheral arterial disease: proteomic profiling and clinical studies.
    Wilson AM; Kimura E; Harada RK; Nair N; Narasimhan B; Meng XY; Zhang F; Beck KR; Olin JW; Fung ET; Cooke JP
    Circulation; 2007 Sep; 116(12):1396-403. PubMed ID: 17724262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Value of adiponectin as predictor of 5-year all-cause mortality in patients with symptomatic peripheral arterial disease: results from the Linz Peripheral Arterial Disease (LIPAD) study.
    Dieplinger B; Haltmayer M; Poelz W; Mueller T
    Clin Chim Acta; 2009 Oct; 408(1-2):87-91. PubMed ID: 19646980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Associations of plasma pro-inflammatory cytokines, fibrinogen, viscosity and C-reactive protein with cardiovascular risk factors and social deprivation: the fourth Glasgow MONICA study.
    Welsh P; Woodward M; Rumley A; Lowe G
    Br J Haematol; 2008 Jun; 141(6):852-61. PubMed ID: 18371109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular risk factor management is poorer in diabetic patients with undiagnosed peripheral arterial disease than in those with known coronary heart disease or cerebrovascular disease. Results of a nationwide study in tertiary diabetes centres.
    González-Clemente JM; Piniés JA; Calle-Pascual A; Saavedra A; Sánchez C; Bellido D; Martín-Folgueras T; Moraga I; Recasens A; Girbés J; Sánchez-Zamorano MA; Mauricio D;
    Diabet Med; 2008 Apr; 25(4):427-34. PubMed ID: 18341592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High prevalence of undiagnosed patients with peripheral arterial disease in patients hospitalised for non-vascular disorders.
    Lacroix P; Aboyans V; Voronin D; Le Guyader A; Cautrès M; Laskar M
    Int J Clin Pract; 2008 Jan; 62(1):59-64. PubMed ID: 18028389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Peripheral arterial disease: predictors and treatment intensity. Two-years of data from the population-based INVADE project].
    Sander K; Bickel H; Schulze Horn C; Huntgeburth U; Poppert H; Sander D
    Dtsch Med Wochenschr; 2008 Mar; 133(10):455-9. PubMed ID: 18302095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparison of two coronary risk equivalents: diabetes mellitus and peripheral arterial disease].
    Darius H; Trampisch HJ; Pittrow D; Allenberg JR; Haberl RL; Mahn M; Tepohl HG; Burghaus I; Diehm C
    Dtsch Med Wochenschr; 2008 Nov; 133(45):2317-22. PubMed ID: 18958826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of peripheral arterial disease on health-related quality of life in the Peripheral Arterial Disease Awareness, Risk, and Treatment: New Resources for Survival (PARTNERS) Program.
    Regensteiner JG; Hiatt WR; Coll JR; Criqui MH; Treat-Jacobson D; McDermott MM; Hirsch AT
    Vasc Med; 2008 Feb; 13(1):15-24. PubMed ID: 18372434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Type-D personality and ankle brachial index as predictors of impaired quality of life and depressive symptoms in peripheral arterial disease.
    Aquarius AE; Denollet J; Hamming JF; Van Berge Henegouwen DP; De Vries J
    Arch Surg; 2007 Jul; 142(7):662-7. PubMed ID: 17638805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of peripheral arterial disease and risk factors in persons aged 60 and older: data from the National Health and Nutrition Examination Survey 1999-2004.
    Ostchega Y; Paulose-Ram R; Dillon CF; Gu Q; Hughes JP
    J Am Geriatr Soc; 2007 Apr; 55(4):583-9. PubMed ID: 17397438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Haemostatic/inflammatory markers predict 10-year risk of IHD at least as well as lipids: the Caerphilly collaborative studies.
    Yarnell JW; Patterson CC; Sweetnam PM; Lowe GD
    Eur Heart J; 2004 Jun; 25(12):1049-56. PubMed ID: 15191776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of European population levels of thrombotic and inflammatory factors with risk of coronary heart disease: the MONICA Optional Haemostasis Study.
    Yarnell J; McCrum E; Rumley A; Patterson C; Salomaa V; Lowe G; Evans A
    Eur Heart J; 2005 Feb; 26(4):332-42; discussion 317-8. PubMed ID: 15618045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An unequal social distribution of peripheral arterial disease and the possible explanations: results from a population-based study.
    Kröger K; Dragano N; Stang A; Moebus S; Möhlenkamp S; Mann K; Siegrist J; Jöckel KH; Erbel R;
    Vasc Med; 2009 Nov; 14(4):289-96. PubMed ID: 19808713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.